IN C004
Alternative Names: IN-C004Latest Information Update: 21 Jan 2022
At a glance
- Originator HK inno.N
- Class Gastrokinetics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Preregistration Gastro-oesophageal reflux
Most Recent Events
- 01 Jan 2022 Preregistration for Gastro-oesophageal reflux (In volunteers) in South Korea (PO) (HK inno.N pipeline, January 2022)
- 05 Feb 2021 HK inno.N completes a phase I trial in healthy volunteers in South Korea (PO) (NCT04654078)
- 18 Jan 2021 HK inno.N initiates enrolment in a phase I trial in Healthy volunteers in South Korea (PO) (NCT04654078)